Skip to main content
SpringerLink
Log in

Antimetastatic drugs: laboratory to clinic

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gilbert, J. M., Hellmann, K., Evans, M., Cassell, P. G., Stoodley, B., Ellis, H., and Wastell, C., 1982, Adjuvant oral razoxane (ICRF159) in resectable colorectal cancer. Cancer Chemotherapy and Pharmacology, 8, 293–299.

    Google Scholar 

  2. Gilbert, J. M., 1983, Distribution of metastases at necropsy in colorectal cancer. Clinical & Experimental Metastasis, 1, 97–101.

    Google Scholar 

  3. Hellmann, K., and Burrage, K., 1969, Control of malignant metastases by ICRF159. Nature, 224, 273–275.

    Google Scholar 

  4. Le Serve, A. W., and Hellmann, K., 1972, Metastases and the normalization of tumour blood vessels by ICRF159: A new type of drug action. British Medical Journal, 1, 597–601.

    Google Scholar 

  5. Gitterman, C. O., and Luell, S., 1973, Chemotherapeutic studies on metastasis of human epidermoid carcinoma (H. Ep.) # 3 in the embryonated chick egg. Chemotherapy of Cancer Dissemination, edited by S. Garattini and G. Franchi (New York: Raven Press), pp. 279–305.

    Google Scholar 

  6. Karrer, K., Humphreys, S. R., and Goldin, A., 1967, An experimental model for studying factors which influence metastasis of malignant tumours. International Journal of Cancer, 2, 213–223.

    Google Scholar 

  7. Salsbury, A. J., Burrage, K., and Hellmann, K., 1974, Historical analysis of the antimetastatic effect of ICRF159. Cancer Research, 34, 843–849.

    Google Scholar 

  8. Talbot, I. C., 1980, The spread of rectal cancer into veins and the mechanism of distant embolism. Metastasis Clinical and Experimental Aspects, edited by K. Hellmann, P. Hilgard and S. Eccles (The Hague: Martinus Nijhoff), pp. 3–8.

    Google Scholar 

  9. White, H., Griffiths, J., and Salsbury, A. J., 1980, Fibrinolysis and anti-coagulation in colorectal cancer-the way ahead. Metastasis Clinical and Experimental Aspects edited by K. Hellmann, P. Hilgard and S. Eccles (The Hague: Martinus Nijhoff), pp. 100–104.

    Google Scholar 

  10. Zacharski, L. R., 1982, The biologic basis for anticoagulant treatment of cancer. Interaction of Platelets and Tumor Cells, edited by G. A. Jamieson (New York: Alan R. Liss Inc), pp. 113–129.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Chemotherapy Department Imperial Cancer Research Fund Lincoln's Inn Fields, WC2, London, UK

    K. Hellmann

  2. Radiotherapy & Oncology Department Westminster Hospital London, SW1, London, UK

    K. Hellmann

Authors
  1. K. Hellmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The substance of this paper was given at a symposium on Experimental Basis of Adjuvant Chemotherapy at the 13th International Chemotherapy Congress, Vienna on 29 August 1983 in honour of the 70th birthday of Abraham Goldin, Scientist Emeritus, National Cancer Institute, Bethesda, USA and Adjunct Professor, Vincent T. Lombardi Cancer Research Center, Washington, D.C., U.S.A.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hellmann, K. Antimetastatic drugs: laboratory to clinic. Clin Exp Metast 2, 1–4 (1984). https://doi.org/10.1007/BF00132302

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00132302

Keywords

Search

Navigation